Status:
COMPLETED
Glucose Variability in Type 1 Diabetes and Its Effect on Factors That Influence New Vessel Formation
Lead Sponsor:
University of Dundee
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The aim of the study is to see how glycaemic control and glycaemic variability affect levels of HIF, VEGF, erythropoietin and cortisol in Paediatric Type 1 diabetics on insulin pump therapy.
Detailed Description
The study will have two parts. The first phase will look at all current paediatric type 1 diabetics in Tayside on continuous subcutaneous insulin pump therapy and measure their levels of Hypoxia-Induc...
Eligibility Criteria
Inclusion
- Phase 1 inclusion:
- Patients with Type 1 Diabetes
- On insulin pump therapy.
- Aged 5 years to 18 years.
- Phase 2 inclusion:
- Patents with Type 1 Diabetes
- Diabetes diagnosis for 1 year
- On insulin pump therapy for minimum of six months
- Access to a computer with internet access and telephone
- Agree to wear CGM for 6 weeks
- Aged 12 years to 18 years
Exclusion
- Patients not on pump therapy
- Patient less than 5 years and greater than 18 years
- Phase 2 patients been on pump therapy for less than 6 months
- Phase 2 patients without access to internet and telephone.
- Phase 2 patients less than 12 years and greater than 18 years
- Patients who do not have a good understanding of English
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01429467
Start Date
August 1 2012
End Date
December 1 2015
Last Update
May 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Of Dundee
Dundee, Angus, United Kingdom, DD1 9SY